Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MGTX | CRML |
|---|---|---|
| Price | $10.59 | $6.86 |
| Change today | ▼ 2.13% | ▼ 2.83% |
| Market cap | $1.02B | $1.01B |
| Return, 3 months | -24.0% | -19.0% |
| Return, year to date | +33.2% | -1.2% |
| Return, 1 year | +28.2% | -41.8% |
| P/E (TTM) | 12.2 | -3.7 |
| P/B | 4.7 | 2.9 |
| P/E percentile vs own 5y | 97th | 39th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +8,608.6% | – |
| Net profit growth (YoY) | +514.1% | -340.0% |
| Gross margin | 97.9% | – |
| Operating margin | 46.3% | – |
| Net margin | 19.9% | – |
| Return on equity | 72.3% | -104.7% |
| Analyst target vs. price | +107.7% | +123.5% |
| Analyst buy share | 83% | 67% |
| RSI (14) | 33 | 47 |
| 30-day volatility | 36.5% | 121.0% |
| Max drawdown, 1 year | -29.2% | -82.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
